AstraZeneca Articles
IQWiG re-assessments come up with same view for saxagliptin and different for crizotinib
14 May 2013
Briefs: New research deals for AstraZeneca and Novo Nordisk; Lundbeck's Selincro launched in Europe
22 April 2013
Briefs: Bidding war for Obagi escalates, as Valeant ups offer; AstraZeneca plans to sue Actavis
3 April 2013
Proposal to list AstraZeneca's Brilinta in New Zealand
26 March 2013
Positive reception for AstraZeneca recovery strategy
22 March 2013
AstraZeneca plans more job cuts; inks $240M-plus deal with Moderna; expands alliance with Karolinska Institutet
21 March 2013
Encouraging results for AstraZeneca's naloxegol in OIC
26 February 2013
Sweden's Orexo in respiratory research accord with AstraZeneca
28 January 2013
Positive outlook for Hutchison China MediTech, say analysts
21 January 2013
AstraZeneca management shakeup sign of major restructuring leading to stock recovery, say analysts
17 January 2013
Flu vaccine innovation needed to protect children, says GlobalData health care expert
13 January 2013
AstraZeneca's Brilinta gains Class I in ACCF/AHA Guidelines; enters deal with Progenics
18 December 2012
News briefs: US Crestor patent upheld; Pfizer animal health plans; Teva South Korea JV
17 December 2012
AstraZeneca presents mixed data on fostamatinib in RA
13 December 2012
Isis on a roll as it signs another licence deal
12 December 2012
News briefs from Bayer, AstraZeneca and Valeant/Galderma
6 December 2012
AstraZeneca inks deal for Optimer's fidaxomicin in Latin America
4 December 2012
Big Pharma doing more for access to medicine in developing countries than two years ago
28 November 2012
Asthma preventive drugs market led by GlaxoSmithKline's Advair
26 November 2012
Clinical briefs from Novartis, Gilead and AstraZeneca
13 November 2012
£7 million funding for MRC-AstraZeneca compound collaboration
30 October 2012
News briefs: Bayer's Stivarga and AstraZeneca's Faslodex
30 October 2012
AstraZeneca 3rd-qtr 2012 takes heavy hit from generics
25 October 2012
AstraZeneca gains rights to sell Ironwood's IBS drug in China
24 October 2012
WuXi AppTec opens first cGMP biologics facility in China
21 October 2012
AstraZeneca's Brilinta rolls out in India
18 October 2012
AstraZeneca gains rights to Ardelyx program; GSK returns cUTI candidate GSK2251052 to Anacor
8 October 2012
News briefs: AstraZeneca suspends share repurchasing; New CMO for Sanofi; Research facility for Octapharma
2 October 2012
Top drugmakers set up non-profit TransCelerate to speed pharma R&D
20 September 2012
Pharmaceutical majors unite in Japan to combat H. pylori
18 September 2012
Rheumatoid arthritis drug market forecast to grow modestly to $15.2 billion in 2021
16 September 2012
Resubmission of aripiprazole NDA accepted; AstraZeneca bond issue
12 September 2012
AstraZeneca drops early-stage obesity drug; Roche loses out on Indian Tarceva dispute
10 September 2012
STEMI guidelines now recommend AstraZeneca's ticagrelor as first-line treatment option
30 August 2012
US genericization of clopidogrel will initially contract ACS market, before uptake of novel oral agents lifts sector to $2.7 billion
27 August 2012
AstraZeneca aligns with Regulus for microRNA therapeutics
16 August 2012
AstraZeneca and Bristol-Myers complete diabetes alliance expansion; Lilly revises guidance
10 August 2012
Alliance Pharma acquires AstraZeneca antimalarial brands
2 August 2012
UK to implement child flu vaccines program
25 July 2012
Ex-AstraZeneca CEO David Brennan to forego bonus
17 July 2012
Germany's IQWiG finds no proof of added benefit for AstraZeneca's Caprelsa in thyroid cancer
5 July 2012
Amylin seduced by $5.3 billion bid from Bristol-Myers; AstraZeneca chips in for share of the action
2 July 2012
- Drug prices to plunge as Indian government announces plans to regulate rates of 652 medicines
- Elan makes "transformational" acquisitions and a divestment
- HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- SciClone gains China rights to Zensun's Neucardin
